Literature DB >> 23567506

The future of/for vanadium.

Dieter Rehder1.   

Abstract

Vanadium compounds are stored or employed by several groups of bacterial and eukaryotic organisms. Two types of vanadium-dependent enzymes have so far been characterised: vanadate-dependent haloperoxidases from fungi, lichens, marine macroalgae and Streptomyces bacteria, and vanadium nitrogenases in proteo- and cyanobacteria. Several bacterial strains can employ vanadate(V) as an external electron acceptor in respiration, reducing vanadate to VO(2+) and thus contributing to the mineralisation of vanadium and to the detoxification of vanadate-contaminated water. Amanita mushrooms and many sea squirts accumulate vanadium, without the importance of this practise being well understood. Further, the analogy between vanadate and phosphate implicates an interference of vanadate with metabolic processes involving phosphate, suggesting a regulatory role for vanadate in most if not all organisms, including humans, but also hinting at toxic effects at unphysiologically high vanadate concentrations. The antidiabetic effect of vanadium compounds is probably related to the phosphate-vanadate antagonism, as is the potentiality of vanadate in the amelioration of cardiovascular affliction. The anti-cancer action of vanadium compounds and their in vitro activity towards the protozoa causing amoebiasis, leishmaniasis and Chagas' disease again may be rooted in the intervention of vanadate with the activity of phosphatases and kinases. In addition, most likely the ability of vanadate(V) and oxidovanadium(IV) to regulate the cellular production of reactive oxygen species comes in, thus influencing cellular signalling. Future developments of vanadium chemistry are likely to emphasize topics related to biological, environmental and medicinal aspects. Condensation of monovanadate results in the formation of oligovanadates, polyvanadates and finally colloidal and solid vanadium oxides that, in part, convey bio-mimetic functions comparable to those of simple vanadate, including its catalytic potential as an active centre in haloperoxidases and the lethal action against viruses, bacteria and protozoan parasites. Decavanadate has been shown to be stabilised by docking to proteins, and by integration into nanoscopic water pools of intracellular compartments, modelled by reverse micelles. The well established and approved use of vanadium oxides in, amongst other applications, catalysis has been recently impacted by the elucidation of the active surface species--VO(x)--of catalysts based on mixed vanadium oxides, and vanadium oxides on supports. Finally, materials based on vanadium oxides and vanadates play an increasingly important role as cathode materials in high density lithium batteries. An example is Ag2VO2PO4, which, in the discharge process, is reduced to Li(3.2)VO2PO4 and Ag. Oncoming developments in vanadium chemistry thus include oxide-based materials.

Entities:  

Year:  2013        PMID: 23567506     DOI: 10.1039/c3dt50457c

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  20 in total

1.  New heteroleptic oxidovanadium(V) complexes: synthesis, characterization and biological evaluation as potential agents against Trypanosoma cruzi.

Authors:  Gonzalo Scalese; Ignacio Machado; Carolina Fontana; Gastón Risi; Gustavo Salinas; Leticia Pérez-Díaz; Dinorah Gambino
Journal:  J Biol Inorg Chem       Date:  2018-09-08       Impact factor: 3.358

Review 2.  The chemical biology and coordination chemistry of putrebactin, avaroferrin, bisucaberin, and alcaligin.

Authors:  Rachel Codd; Cho Zin Soe; Amalie A H Pakchung; Athavan Sresutharsan; Christopher J M Brown; William Tieu
Journal:  J Biol Inorg Chem       Date:  2018-06-26       Impact factor: 3.358

3.  Toxicity of Nanocomplexes Containing Gadolinium Orthovanadate Nanoparticles and Cholesterol.

Authors:  Anatoliy Goltsev; Natalia Babenko; Yuliia Gaevska; Mykola Bondarovych; Tetiana Dubrava; Lyudmila Ostankova; Nataliia Volkova; Vladimir Klochkov
Journal:  Biol Trace Elem Res       Date:  2022-01-13       Impact factor: 4.081

4.  Biotransformations of Antidiabetic Vanadium Prodrugs in Mammalian Cells and Cell Culture Media: A XANES Spectroscopic Study.

Authors:  Aviva Levina; Andrew I McLeod; Anna Pulte; Jade B Aitken; Peter A Lay
Journal:  Inorg Chem       Date:  2015-04-23       Impact factor: 5.165

5.  A cross-sectional study measuring vanadium and chromium levels in paediatric patients with CKD.

Authors:  Guido Filler; Marta Kobrzynski; Hargun Kaur Sidhu; Vladimir Belostotsky; Shih-Han S Huang; Chris McIntyre; Liju Yang
Journal:  BMJ Open       Date:  2017-06-06       Impact factor: 2.692

6.  Characterization and cytotoxic effect of aqua-(2,2',2''-nitrilotriacetato)-oxo-vanadium salts on human osteosarcoma cells.

Authors:  Aleksandra Tesmar; Dariusz Wyrzykowski; Rafał Kruszyński; Karolina Niska; Iwona Inkielewicz-Stępniak; Joanna Drzeżdżon; Dagmara Jacewicz; Lech Chmurzyński
Journal:  Biometals       Date:  2017-02-15       Impact factor: 2.949

7.  Design, synthesis and pharmacological evaluation of novel vanadium-containing complexes as antidiabetic agents.

Authors:  Elena V Fedorova; Anna V Buryakina; Alexey V Zakharov; Dmitry A Filimonov; Alexey A Lagunin; Vladimir V Poroikov
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

8.  Metforminium Decavanadate as a Potential Metallopharmaceutical Drug for the Treatment of Diabetes Mellitus.

Authors:  Samuel Treviño; Denisse Velázquez-Vázquez; Eduardo Sánchez-Lara; Alfonso Diaz-Fonseca; José Ángel Flores-Hernandez; Aarón Pérez-Benítez; Eduardo Brambila-Colombres; Enrique González-Vergara
Journal:  Oxid Med Cell Longev       Date:  2016-03-28       Impact factor: 6.543

Review 9.  Why Antidiabetic Vanadium Complexes are Not in the Pipeline of "Big Pharma" Drug Research? A Critical Review.

Authors:  Thomas Scior; Jose Antonio Guevara-Garcia; Quoc-Tuan Do; Philippe Bernard; Stefan Laufer
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

10.  Cytotoxicity and enzyme inhibition studies of polyoxometalates and their chitosan nanoassemblies.

Authors:  Hamid Saeed Shah; Rami Al-Oweini; Ali Haider; Ulrich Kortz; Jamshed Iqbal
Journal:  Toxicol Rep       Date:  2014-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.